Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 239
Appendix C
Task Forces
TASK FORCE 1 - STRENGTHS ANI) WEAKNESSES OF THE
CURRENT SYSTEM
Committee Members
FI~OYD E. BLOOM (Chair), Chairman, Department of
Neuropharmacology, Research Institute of Scripps Clinic, La Jolla,
California
HENRY J. AARON, Senior Fellow, The Broo~ngs Institution,
Washington, D.C.
MAUREEN M. HENDERSON, Professor of Epidemiology and
Medicine, University of Washington, Fred Hutchinson Cancer
Research Center, Seattle, Washington
DON K PRICE, Professor of Public Management, Emeritus, John F.
Kennedy School of Government, Harvard University, Cambridge,
Massachusetts
HOWARD E. FREEMAN, Professor, Department of Sociology,
University of California at Los Angeles, Los Angeles, California
239
OCR for page 240
240
Invited Guests
ROBERT W. BERLINER, Professor of Physiology and Medicine,
Emeritus, Department of Physiology, Yale University School of
Medicine, New Haven, Connecticut
APPENDIX C
JOEL W. GOLDSTEIN, Deputy Associate Administrator for Extramural
Programs & Director, Division of Program Analysis, Alcohol, Drug
Abuse and Mental Health Administration, Rockville, Maryland
WILLIAM F. DAUB, Deputy Director, National Institutes of Health
PETER GREENWALD, Director, Division of Cancer Prevention and
Control, National Cancer Institute, Bethesda, Maryland
TASK FORCE 2 - GOALS OF BIOMEDICAL RESEARCH
Committee Members
RALPH I. HORWITZ (Chair), Professor, Department of Medicine, Yale
University, New Haven, Connecticut
MANNA H. GRAY, President and Professor of History, University of
Chicago, Chicago, Illinois
ERNEST G. JAWORSKI, Distinguished Science Fellow and Director of
Biological Sciences, Monsanto Company, St. Louis, Missouri
THOMAS W. LANGFI1T, (ex officio member) President and Chief
Executive Officer, The Glenmede llust Company and the Pew
Charitable [lusts, Philadelphia, Pennsylvania
Invited Guest
JUDITH RODIN, Phillip R. Allen Professor of Psychology, Professor of
Medicine and Psychiatry, Yale University
TASK FORCE 3 - OPTIMIZING THE ENVIRONMENT FOR
BIOMEDICAL RESEARCH
Committee Members
KENNETH I. SHINE (Chair), Dean, School of Medicine, University of
California at Los Angeles, Los Angeles, California
SAMUEL HELLMAN, Dean, Division of Biological Sciences and the
Pritzker School of Medicine, and Vice President for the Medical
Center, University of Chicago, Chicago, Illinois
ARIEL G. LOEWY, Jack and Barbara Bush Professor in the Natural
Sciences and Chairman, Department of Biology, Haverford College,
Haverford, Pennsylvania
OCR for page 241
TASK FORCES
241
P. DENNIS SMITH, Chairman, Department of Biological Sciences,
Wayne State University, Detroit, Michigan
JACK D. BARCHAS, Associate Dean for Neuroscience and Professor of
Neuroscience and Biobehavioral Sciences, School of Medicine,
University of California at Los Angeles, Los Angeles, California
Invited Guests
IVAN Lo BENNETT, Professor of Medicine, New York University
Medical Center, New York, New York
TONY MERRITT, Office of Grants and Contracts, University of
Pennsylvania, Philadelphia, Pennsylvania
Representative terms from entire chapter:
california samuel
